Scarica l'app Stockscreener
94.31
0.61%
-0.58
Pre-mercato:
94.08
-0.23
-0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NFLX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$94.89
Aprire:
$94.86
Volume 24 ore:
34.15M
Relative Volume:
0.67
Capitalizzazione di mercato:
$398.19B
Reddito:
$45.27B
Utile/perdita netta:
$10.98B
Rapporto P/E:
37.32
EPS:
2.5272
Flusso di cassa netto:
$9.46B
1 W Prestazione:
-4.90%
1M Prestazione:
+24.32%
6M Prestazione:
-20.64%
1 anno Prestazione:
+2.55%
Intervallo 1D:
$93.87
$95.40
Intervallo di 1 settimana:
$93.87
$99.88
Portata 52W:
$75.01
$134.12
Netflix Inc Stock (NFLX) Company Profile
Nome
Netflix Inc
Settore
Industria
Telefono
408-540-3700
Indirizzo
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, WBD, LYV, FOXA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
94.31 | 398.19B | 45.27B | 10.98B | 9.46B | 2.5272 |
|
DIS
Walt Disney Co
|
99.43 | 176.14B | 95.62B | 13.27B | 7.06B | 6.7872 |
|
WBD
Warner Bros Discovery Inc
|
27.43 | 68.05B | 37.32B | 749.00M | 3.09B | 0.2873 |
|
LYV
Live Nation Entertainment Inc
|
160.32 | 37.64B | 25.20B | 139.94M | 304.98M | -0.2348 |
|
FOXA
Fox Corporation
|
57.74 | 24.56B | 16.58B | 1.93B | 2.31B | 4.1552 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-09 | Ripresa | Wells Fargo | Equal Weight |
| 2026-03-02 | Ripresa | Barclays | Equal Weight |
| 2026-03-02 | Ripresa | JP Morgan | Overweight |
| 2026-02-27 | Aggiornamento | Arete | Neutral → Buy |
| 2026-02-27 | Ripresa | Evercore ISI | Outperform |
| 2026-01-23 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-21 | Reiterato | BMO Capital Markets | Outperform |
| 2026-01-21 | Reiterato | Canaccord Genuity | Buy |
| 2026-01-21 | Reiterato | Deutsche Bank | Hold |
| 2026-01-21 | Reiterato | Goldman | Neutral |
| 2026-01-21 | Reiterato | Guggenheim | Buy |
| 2026-01-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-21 | Reiterato | Morgan Stanley | Overweight |
| 2026-01-21 | Reiterato | Needham | Buy |
| 2026-01-21 | Reiterato | Oppenheimer | Outperform |
| 2026-01-21 | Reiterato | Piper Sandler | Overweight |
| 2026-01-21 | Reiterato | Pivotal Research Group | Hold |
| 2026-01-21 | Reiterato | Rosenblatt | Neutral |
| 2026-01-21 | Reiterato | Rothschild & Co Redburn | Buy |
| 2026-01-21 | Reiterato | TD Cowen | Buy |
| 2026-01-21 | Reiterato | UBS | Buy |
| 2026-01-21 | Reiterato | Wolfe Research | Outperform |
| 2026-01-12 | Iniziato | HSBC Securities | Buy |
| 2026-01-09 | Reiterato | Goldman | Neutral |
| 2025-12-08 | Downgrade | Pivotal Research Group | Buy → Hold |
| 2025-12-08 | Downgrade | Rosenblatt | Buy → Neutral |
| 2025-11-18 | Reiterato | Barclays | Equal Weight |
| 2025-10-31 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-07 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-09-17 | Aggiornamento | Loop Capital | Hold → Buy |
| 2025-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-07-07 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2025-07-02 | Reiterato | Canaccord Genuity | Buy |
| 2025-07-02 | Reiterato | Goldman | Neutral |
| 2025-06-20 | Reiterato | Pivotal Research Group | Buy |
| 2025-06-12 | Reiterato | Oppenheimer | Outperform |
| 2025-06-03 | Reiterato | Jefferies | Buy |
| 2025-05-30 | Reiterato | BofA Securities | Buy |
| 2025-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-04-21 | Reiterato | BMO Capital Markets | Outperform |
| 2025-04-21 | Reiterato | Barclays | Equal Weight |
| 2025-04-21 | Reiterato | Canaccord Genuity | Buy |
| 2025-04-21 | Reiterato | Guggenheim | Buy |
| 2025-04-21 | Reiterato | JP Morgan | Overweight |
| 2025-04-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-04-21 | Reiterato | MoffettNathanson | Buy |
| 2025-04-21 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-21 | Reiterato | Oppenheimer | Outperform |
| 2025-04-21 | Reiterato | Piper Sandler | Overweight |
| 2025-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2025-04-21 | Reiterato | Wells Fargo | Overweight |
| 2025-04-17 | Ripresa | Piper Sandler | Overweight |
| 2025-03-27 | Iniziato | FBN Securities | Outperform |
| 2025-03-17 | Aggiornamento | MoffettNathanson | Neutral → Buy |
| 2025-01-24 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-23 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-01-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2025-01-22 | Reiterato | Oppenheimer | Outperform |
| 2025-01-22 | Reiterato | Pivotal Research Group | Buy |
| 2025-01-22 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2025-01-22 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2025-01-16 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-01-15 | Reiterato | BMO Capital Markets | Outperform |
| 2025-01-15 | Reiterato | Oppenheimer | Outperform |
| 2025-01-08 | Reiterato | Goldman | Neutral |
| 2025-01-06 | Reiterato | Argus | Buy |
| 2025-01-03 | Reiterato | The Benchmark Company | Sell |
| 2024-12-19 | Reiterato | UBS | Buy |
| 2024-12-16 | Downgrade | Loop Capital | Buy → Hold |
| 2024-12-16 | Reiterato | Oppenheimer | Outperform |
| 2024-12-11 | Reiterato | JP Morgan | Overweight |
| 2024-11-20 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-18 | Reiterato | Needham | Buy |
| 2024-10-18 | Reiterato | Oppenheimer | Outperform |
| 2024-10-18 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-16 | Reiterato | Loop Capital | Buy |
| 2024-10-11 | Reiterato | Guggenheim | Buy |
| 2024-10-10 | Reiterato | Morgan Stanley | Overweight |
| 2024-10-10 | Reiterato | Oppenheimer | Outperform |
| 2024-10-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2024-10-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-10-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-09-05 | Iniziato | China Renaissance | Hold |
| 2024-08-30 | Reiterato | Pivotal Research Group | Buy |
| 2024-07-17 | Reiterato | Guggenheim | Buy |
| 2024-07-16 | Reiterato | The Benchmark Company | Sell |
| 2024-07-15 | Reiterato | BofA Securities | Buy |
| 2024-07-12 | Reiterato | JP Morgan | Overweight |
| 2024-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-07-09 | Reiterato | TD Cowen | Buy |
| 2024-07-02 | Reiterato | Argus | Buy |
| 2024-05-28 | Reiterato | Evercore ISI | Outperform |
| 2024-04-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-04-19 | Aggiornamento | Needham | Hold → Buy |
| 2024-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2024-04-15 | Reiterato | Deutsche Bank | Hold |
| 2024-04-12 | Reiterato | Morgan Stanley | Overweight |
| 2024-04-12 | Reiterato | Piper Sandler | Neutral |
| 2024-04-05 | Reiterato | Pivotal Research Group | Buy |
| 2024-03-25 | Reiterato | Citigroup | Neutral |
| 2024-03-12 | Reiterato | Jefferies | Buy |
| 2024-03-11 | Reiterato | Oppenheimer | Outperform |
| 2024-01-30 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2024-01-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2024-01-24 | Reiterato | BMO Capital Markets | Outperform |
| 2024-01-24 | Reiterato | BofA Securities | Buy |
| 2024-01-24 | Reiterato | Canaccord Genuity | Buy |
| 2024-01-24 | Reiterato | Evercore ISI | Outperform |
| 2024-01-24 | Reiterato | Goldman | Neutral |
| 2024-01-24 | Reiterato | Guggenheim | Buy |
| 2024-01-24 | Reiterato | JP Morgan | Overweight |
| 2024-01-24 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-01-24 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2024-01-24 | Reiterato | Morgan Stanley | Overweight |
| 2024-01-24 | Reiterato | Oppenheimer | Outperform |
| 2024-01-24 | Reiterato | Piper Sandler | Neutral |
| 2024-01-24 | Reiterato | Pivotal Research Group | Buy |
| 2024-01-24 | Reiterato | Redburn Atlantic | Buy |
| 2024-01-24 | Reiterato | Robert W. Baird | Outperform |
| 2024-01-24 | Reiterato | TD Cowen | Outperform |
| 2024-01-24 | Reiterato | UBS | Buy |
| 2024-01-24 | Reiterato | Wells Fargo | Overweight |
| 2023-09-18 | Reiterato | Evercore ISI | Outperform |
| 2023-08-25 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-07-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-07-17 | Reiterato | Deutsche Bank | Buy |
| 2023-07-13 | Reiterato | JP Morgan | Overweight |
| 2023-07-12 | Reiterato | UBS | Buy |
| 2023-07-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-29 | Reiterato | Citigroup | Buy |
| 2023-06-28 | Reiterato | Oppenheimer | Outperform |
| 2023-06-13 | Reiterato | BofA Securities | Buy |
| 2023-06-13 | Reiterato | Guggenheim | Buy |
| 2023-04-19 | Reiterato | Deutsche Bank | Buy |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Jefferies | Buy |
| 2023-04-19 | Reiterato | Piper Sandler | Neutral |
| 2023-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2023-04-19 | Reiterato | Rosenblatt | Neutral |
| 2023-04-19 | Aggiornamento | UBS | Neutral → Buy |
| 2023-04-11 | Ripresa | Robert W. Baird | Neutral |
| 2023-01-23 | Reiterato | Argus | Buy |
| 2023-01-20 | Reiterato | Canaccord Genuity | Buy |
| 2023-01-20 | Reiterato | Deutsche Bank | Buy |
| 2023-01-20 | Reiterato | Evercore ISI | Outperform |
| 2023-01-20 | Reiterato | Goldman | Sell |
| 2023-01-20 | Reiterato | Guggenheim | Buy |
| 2023-01-20 | Reiterato | Jefferies | Buy |
| 2023-01-20 | Reiterato | MoffettNathanson | Market Perform |
| 2023-01-20 | Reiterato | Oppenheimer | Outperform |
| 2023-01-20 | Reiterato | Piper Sandler | Neutral |
| 2023-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2023-01-20 | Reiterato | Robert W. Baird | Neutral |
| 2023-01-20 | Reiterato | The Benchmark Company | Sell |
| 2023-01-20 | Reiterato | Wedbush | Outperform |
| 2023-01-20 | Reiterato | Wolfe Research | Outperform |
| 2023-01-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-04 | Iniziato | New Street | Neutral |
| 2022-12-29 | Aggiornamento | CFRA | Sell → Buy |
| 2022-12-14 | Reiterato | Jefferies | Hold |
| 2022-12-09 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-06-14 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-06-10 | Downgrade | Goldman | Neutral → Sell |
| 2022-05-16 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-04-21 | Downgrade | DZ Bank | Buy → Hold |
| 2022-04-21 | Downgrade | Edward Jones | Buy → Hold |
| 2022-04-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-04-20 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-04-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-20 | Aggiornamento | Needham | Underperform → Hold |
| 2022-04-20 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | Pivotal Research Group | Buy → Sell |
| 2022-04-20 | Downgrade | Stifel | Buy → Hold |
| 2022-04-20 | Downgrade | UBS | Buy → Neutral |
| 2022-04-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-19 | Iniziato | Rosenblatt | Neutral |
| 2022-03-09 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-01-24 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-21 | Reiterato | BMO Capital Markets | Outperform |
| 2022-01-21 | Reiterato | BofA Securities | Buy |
| 2022-01-21 | Reiterato | Canaccord Genuity | Buy |
| 2022-01-21 | Reiterato | Cowen | Outperform |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Goldman | Neutral |
| 2022-01-21 | Reiterato | Guggenheim | Buy |
| 2022-01-21 | Reiterato | JP Morgan | Overweight |
| 2022-01-21 | Reiterato | MoffettNathanson | Neutral |
| 2022-01-21 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2022-01-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-21 | Reiterato | Oppenheimer | Outperform |
| 2022-01-21 | Reiterato | Piper Sandler | Overweight |
| 2022-01-21 | Reiterato | Pivotal Research Group | Buy |
| 2022-01-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2022-01-21 | Downgrade | Truist | Buy → Hold |
| 2022-01-21 | Reiterato | UBS | Buy |
| 2022-01-21 | Reiterato | Wolfe Research | Outperform |
| 2021-12-15 | Reiterato | The Benchmark Company | Sell |
| 2021-10-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-10-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-09-29 | Reiterato | The Benchmark Company | Sell |
| 2021-09-13 | Iniziato | Goldman | Neutral |
| 2021-09-08 | Reiterato | JP Morgan | Overweight |
| 2021-09-07 | Reiterato | Atlantic Equities | Overweight |
| 2021-07-21 | Reiterato | Credit Suisse | Outperform |
| 2021-07-21 | Reiterato | Deutsche Bank | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-06-25 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-06-25 | Iniziato | Edward Jones | Hold |
| 2021-05-19 | Ripresa | Jefferies | Buy |
| 2021-04-21 | Ripresa | Oppenheimer | Outperform |
| 2021-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2021-04-21 | Aggiornamento | Stifel | Hold → Buy |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-04-01 | Iniziato | Piper Sandler | Overweight |
| 2021-03-25 | Reiterato | The Benchmark Company | Sell |
| 2021-03-23 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-21 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-01-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2021-01-20 | Reiterato | The Benchmark Company | Sell |
| 2021-01-20 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-10-21 | Reiterato | BMO Capital Markets | Outperform |
| 2020-10-21 | Reiterato | Bernstein | Outperform |
| 2020-10-21 | Reiterato | Jefferies | Buy |
| 2020-10-21 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-21 | Reiterato | Oppenheimer | Outperform |
| 2020-10-21 | Reiterato | Piper Sandler | Overweight |
| 2020-10-21 | Reiterato | Pivotal Research Group | Buy |
| 2020-10-21 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-21 | Reiterato | The Benchmark Company | Sell |
| 2020-10-21 | Reiterato | Wedbush | Underperform |
| 2020-10-21 | Reiterato | Wells Fargo | Equal Weight |
| 2020-10-16 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-15 | Reiterato | Canaccord Genuity | Buy |
| 2020-10-14 | Reiterato | Goldman | Buy |
| 2020-10-07 | Reiterato | Pivotal Research Group | Buy |
| 2020-09-28 | Reiterato | The Benchmark Company | Sell |
| 2020-09-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-09 | Ripresa | Raymond James | Mkt Perform |
| 2020-09-04 | Reiterato | The Benchmark Company | Sell |
| 2020-07-29 | Reiterato | Loop Capital | Buy |
Mostra tutto
Netflix Inc Borsa (NFLX) Ultime notizie
The Oscars’ Best Picture category exposes a harsh new reality for Hollywood - Fortune
Netflix's exclusive WBC broadcasting deal in Japan draws mixed reactions - 毎日新聞
Netflix’s InterPositive AI deal favors optimization over automation - eMarketer
‘War Machine’ Is Latest Netflix Action Flick to Top Streaming Chart - IMDb
Ben Affleck 'scores $600m deal' with Netflix to sell his AI film start-up - Daily Mail
3 Industry-Leading Consumer Companies Using Artificial Intelligence (AI) in Unique Ways - The Motley Fool
Link: Netflix simpler story without Warner Bros. Discovery deal - Yahoo Finance
Ben Affleck Just Sold His Stealth AI Startup to Netflix for $600 Million. Here’s What It Actually Does - inc.com
Netflix’s Diego Ávalos Pitches Accessibility and Flexibility to Emerging Spanish Talent at Málaga - IMDb
What's Going On With Netflix Stock Thursday?Netflix (NASDAQ:NFLX) - Benzinga
Netflix Confirms Sequel to Blockbuster ‘KPop Demon Hunters’ Film - Bloomberg.com
Netflix confirms sequel to KPop Demon Hunters in the works (NFLX:NASDAQ) - Seeking Alpha
Mistakes Are Made in the Trailer for Dan Levy’s New Netflix Comedy ‘Big Mistakes’ - IMDb
‘KPop Demon Hunters’ Sequel Officially Set at Netflix With Original Directors - IMDb
‘KPop Demon Hunters’ Sequel Officially a Go From Netflix, Sony With Directors Maggie Kang and Chris Appelhans Returning - IMDb
Netflix Unveils Visual Effects Studio In Hyderabad - Inc42
Netflix lays off part of its marketing team 💡 - XTB.com
Jada Pinkett Smith to Reprise ‘A Different World’ Role in Netflix Sequel Series - IMDb
Boston restaurant hosts kickoff breakfast for Netflix star’s real estate firm - Boston 25 News
Netflix Makes Cuts to Global Product Team as Part of Reorg - IMDb
Finneas O’Connell to Score ‘Beef’ Season 2 - IMDb
‘Big Mistakes’ Trailer: Dan Levy Stars as an Incompetent Criminal in Netflix Comedy Series - IMDb
Netflix is spending up to $600 million to buy Ben Affleck’s AI startup. What exactly is it buying? - MarketWatch
Netflix Has No Rivals - Yahoo Finance
Frida Kahlo, Diego Rivera Netflix Series in the Works (Exclusive) - IMDb
Phoebe Dynevor’s Shark Movie Gets New Title, First Trailer After Pivot to Netflix - IMDb
Argus lowers Netflix stock price target on acquisition concerns - Investing.com Australia
Netflix Stock Holds Near $100 After $600M InterPositive AI Deal - eand.co
Netflix’s Eyeline Studios Opens Hyderabad Facility in Major Long-Term India Investment - IMDb
Ben Affleck quietly built an AI filmmaking startup with just 16 employees, patented its cinematic logic, and sold it to Netflix for up to $600 million - Luxurylaunches
Netflix AI filmmaking push grows with InterPositive acquisition - Digital Watch Observatory
Connor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Netflix reportedly paying $600m for Ben Affleck’s AI software company - Film Stories
Netflix (NFLX) Stock; Slightly Declines After $600M Ben Affleck AI Deal - CoinCentral
Netflix to pay as much as $600 million for AI filmmaking firm InterPositive - The Hindu
Netflix Reportedly in Talks to Acquire AI Film Company for Up to $600 Million, Wall Street Remains Optimistic - NAI500
Netflix Could Pay as Much as $600 Million for Ben Affleck’s AI Film Start-Up: Report - IMDb
Netflix’s Warner Bros. Bid Failed. What Should It Buy Now? - ADWEEK
Netflix to Pay Up to $600 Million for Ben Affleck’s AI Company - IMDb
Ben Affleck Just Sold His AI Filmmaking Company To Netflix For $600 MILLIONHow Do You Like Them Apples? - Celebrity Net Worth
Ben Affleck's AI company is now part of Netflix - NewsBytes
Netflix may have paid $600 million for Ben Affleck’s AI startup - Yahoo Finance
Netflix Rival Strikes Deal With Google in Battle for AI Content - Barron's
Netflix to Pay as Much as $600 Million for Ben Affleck’s AI Firm - Bloomberg.com
Netflix (NFLX) Stock Predictions for 2026 and Beyond - The Motley Fool
Netflix To Reportedly Pay Up To $600M For Ben Affleck’s InterPositive - Stocktwits
Denzel Washington and Antoine Fuqua’s Hannibal Epic for Netflix Sets Summer Shoot in Italy (Exclusive) - IMDb
Meet Will Ferrell’s 'The Hawk,' teeing off this summer on Netflix - PGA Tour
Netflix (NFLX) Stock Quotes, Company News And Chart Analysis - Investor's Business Daily
WWE Announces New International Broadcast Deal With Netflix - Wrestling Inc.
Netflix Thriller ‘Firebreak’: Director David Victori Unpacks the Craft Behind the Breakout Hit - IMDb
Netflix Inc Azioni (NFLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):